Singapore Firm Draws Warning for Unapproved Drug, Quality Violations

Drug Industry Daily
A A
Luen Fook Medicine’s Singapore facility drew a warning letter from the FDA for making unapproved drug claims and for repeat quality violations.

To View This Article:

Login

Subscribe To Drug Industry Daily